The sponsor’s manufacturing order is the written, formally authorized instruction to a manufacturer to process, package, and/or distribute a specified number of units of an investigational medicinal product. It is issued by the sponsor or on the sponsor’s behalf and retained as part of the batch documentation. Its content must be unambiguous enough that the manufacturer does not need to interpret either the quantity or the intended scope of work.
Trigger for a Specific Manufacturing or Supply Action
The manufacturing order implements the product-specific requirements for a single operational request. It does not state in general terms that an investigational medicinal product should be developed or kept available, but instead requires a specific processing, packaging, or distribution activity for a defined number of units. It therefore constitutes the documented trigger on the basis of which a manufacturer opens the corresponding batch and record documentation.
The guideline requires written form but permits electronic transmission. What matters is not the medium of transmission, but formal authorization and clarity. An order that, for example, leaves the required unit quantity or the scope of packaging undefined improperly shifts decisions into manufacturing practice and cannot be reliably assessed when reconstructing a delivery.
In blinded studies, the order may trigger a packaging or shipping requirement whose practical implementation must be aligned with randomization, labeling, and the clinical trial protocol. The order itself does not replace these references. Precisely for this reason, it must refer to the product specification file and, where applicable, to the relevant clinical trial protocol.
Role Within the Batch Documentation
The manufacturer retains the manufacturing order within the batch documentation. This makes it possible to trace, for a given batch or supply scope, who initiated the activity, what quantity was requested, and which requirements served as the reference. The manufacturing formula, processing instructions, packaging instructions, test reports, and shipping-related documents remain separate records; the order links them to the requirement triggered by the sponsor.
This is particularly important for repeat deliveries. An adjusted quantity is not merely a logistical notification if it triggers a new packaging or distribution action. The current order must then be consistent with the approved documentation and the valid version of the product specification file. During an inspection, this allows verification that actions were taken strictly within the requested and authorized scope.
The sponsor may delegate the issuing of the order organizationally. However, the guideline specifies that the order must be formally authorized by the sponsor or the sponsor’s representative. A mere internal demand notice from the manufacturer does not meet this standard unless it carries the required sponsor reference and the necessary authorization.
Distinction from a Commercial Purchase Order
The manufacturing order is not a commercial purchase order. A purchase order typically governs price, invoicing, delivery date, or procurement; the manufacturing order, by contrast, is a GMP document with an explicitly defined function within the batch documentation. Its content concerns the authorized manufacturing activity or distribution of investigational medicinal product units, not contractual remuneration.
Within a given project, a purchase order and a manufacturing order may reference the same quantity, but they are not interchangeable. The purchase order does not provide evidence of the sponsor’s unambiguous approval to carry out a GMP-relevant activity. Conversely, the manufacturing order need not contain any commercial terms. This separation prevents business documents from being mistaken for manufacturing instructions within the batch documentation.
Relevance for clinical trials
Manufacturing orders govern the interface between study planning and supply. When a country is activated at a later stage, recruitment proceeds faster than expected, or blinded re-packaging becomes necessary, the order must translate the planned quantity precisely into an executable GMP action. Poorly coordinated orders can lead to discrepancies between the packaging plan, labeling, available released quantity, and the actual needs of the trial sites.
Full-service CROs such as Mediconomics support the alignment of demand forecasts with sponsor approvals, the documentation of handover to manufacturers and depots, and the verification that the order, study protocol, randomization strategy, and approved labeling all reflect the same current version. This ensures that it remains traceable which study requirement triggered a specific manufacturing or supply action.
A properly maintained manufacturing order also enables quantity reconciliation across rejects, retention samples, and distribution, without blending these elements into the order itself. This becomes especially apparent with small clinical batches, where the requested unit quantity must be precisely fixed in writing.
Frequently Asked Questions (FAQ)
May a manufacturing order be transmitted electronically?
Yes. The guideline permits electronic transmission but requires a written, clearly formulated order that is formally authorized by the sponsor or the sponsor’s representative.
Must every order reference the clinical trial protocol?
The order should refer to the product specification file and, where applicable, to the relevant clinical trial protocol. Which reference is required depends on the requested activity.
Can the manufacturer initiate an order on its own?
The order must be issued to the manufacturer by the sponsor or on the sponsor’s behalf. The manufacturer may provide demand or planning data, but this does not substitute for formal sponsor authorization.
Regulatory References
- Detailed Commission Guidelines C(2017) 8179 final, Section 5.2 – defines requirements for the order for investigational medicinal products.
- Detailed Commission Guidelines C(2017) 8179 final, Section 5.3 – requires written instructions and records for manufacturing and supply.
- Commission Delegated Regulation (EU) 2017/1569, Article 8 – governs the GMP-compliant maintenance and retention of documentation.